Wang Chang-Guo, Li Chang, Lei Wei, Jiang Jun-Hong, Huang Jian-An, Zeng Da-Xiong
Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
Department of Thoracic Surgery, First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
Int J Chron Obstruct Pulmon Dis. 2018 Apr 13;13:1177-1186. doi: 10.2147/COPD.S151820. eCollection 2018.
Chronic hypoxia-induced pulmonary vascular remodeling is a feature of chronic obstructive pulmonary disease (COPD). Our previous reports indicate that neuron-derived orphan receptor 1 (NOR1) promoted pulmonary smooth muscle cell proliferation in vitro. But it remains unclear whether NOR1 participated into hypoxia-induced pulmonary vascular remodeling in COPD patients.
For this study, we collected peripheral lung tissues of 26 male COPD patients with or without hypoxemia. We detected the pulmonary vascular remodeling in all the peripheral lung tissues. Primary human pulmonary arterial smooth muscle cells were also cultured in vitro and stimulated with hypoxia or normoxia. Cell proliferation and protein levels were detected.
COPD patients with hypoxemia showed significantly enlarged pulmonary vessels wall thickness and increased protein levels of HIF-1α, smooth muscle actin, cyclin D1, and NOR1 when compared with those in normoxic patients. Moreover, hypoxia induced human pulmonary arterial smooth muscle cell proliferation and NOR1 overexpression in vitro. The plasmid-based NOR1 gene overexpression markedly promoted DNA synthesis and proliferation in hypoxia or normoxic cells. Human NOR1 gene-specific siRNA intensively suppressed DNA synthesis and proliferation. Transfection of NOR1 overexpression plasmid raised cyclin D1 protein levels, which could be significant inhibited by NOR1-specific siRNA or a CDK4/6 inhibitor PD0332991.
We concluded that NOR1 upregulation is associated with hypoxia-induced pulmonary vascular remodeling in COPD via promoting human pulmonary arterial smooth muscle cell proliferation.
慢性缺氧诱导的肺血管重塑是慢性阻塞性肺疾病(COPD)的一个特征。我们之前的报告表明,神经元衍生的孤儿受体1(NOR1)在体外促进肺平滑肌细胞增殖。但尚不清楚NOR1是否参与COPD患者缺氧诱导的肺血管重塑。
在本研究中,我们收集了26名有或无低氧血症的男性COPD患者的外周肺组织。我们检测了所有外周肺组织中的肺血管重塑情况。还在体外培养了原代人肺动脉平滑肌细胞,并用缺氧或常氧刺激。检测细胞增殖和蛋白质水平。
与常氧患者相比,低氧血症的COPD患者肺血管壁厚度显著增加,HIF-1α、平滑肌肌动蛋白、细胞周期蛋白D1和NOR1的蛋白质水平升高。此外,缺氧在体外诱导人肺动脉平滑肌细胞增殖和NOR1过表达。基于质粒的NOR1基因过表达显著促进了缺氧或常氧细胞中的DNA合成和增殖。人NOR1基因特异性siRNA强烈抑制DNA合成和增殖。NOR1过表达质粒转染提高了细胞周期蛋白D1蛋白水平,而NOR1特异性siRNA或CDK4/6抑制剂PD0332991可显著抑制该水平。
我们得出结论,NOR1上调通过促进人肺动脉平滑肌细胞增殖与COPD中缺氧诱导的肺血管重塑相关。